Bone Marrow Transplant Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Conditions: Graft Vs Host Disease; Haematological Malignancy; Cancer Intervention: Sponsor: The University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Conditions: Graft Vs Host Disease; Haematological Malignancy; Cancer Intervention: Sponsor: The University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Conditions: Graft Vs Host Disease; Haematological Malignancy; Cancer Intervention: Sponsor: The University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Conditions: Graft Vs Host Disease; Haematological Malignancy; Cancer Intervention: Sponsor: The University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Conditions: Graft Vs Host Disease; Haematological Malignancy; Cancer Intervention: Sponsor: The University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2021 Category: Research Source Type: clinical trials
Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza
Condition: Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Placebo; Drug: Oseltamivir Sponsors: Weill Medical College of Cornell University; Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2021 Category: Research Source Type: clinical trials
Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction
Condition: Renal Transplantation Intervention: Combination Product: Combined kidney and bone marrow transplantation Sponsor: Rabin Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2021 Category: Research Source Type: clinical trials
